Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Waller

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Pharmacoepidemiology and Drug Safety|February 7, 2002
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reportsS J Evans, P C Waller, S Davis
Postgraduate Medical Journal|February 1, 1988
Prolongation of the QT interval by ketanserinH A Cameron, P C Waller, L E Ramsay
Pharmacoepidemiology and Drug Safety|November 1, 1996
Regulatory pharmacovigilance in the United Kingdom: current principles and practiceP C Waller, R A Coulson, S M Wood
Drugs & Aging|March 1, 1992
Pharmacological approaches to the treatment of intermittent claudicationE G Bevan, P C Waller, L E Ramsay
British Journal of Clinical Pharmacology|November 1, 1988
Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965-1985H A Cameron, P C Waller, L E Ramsay
Postgraduate Medical Journal|April 1, 1987
Profound hypotension after the first dose of ketanserinP C Waller, H A Cameron, L E Ramsay
Angiology|March 1, 1989
The acute effects of cigarette smoking on treadmill exercise distances in patients with stable intermittent claudicationP C Waller, S A Solomon, L E Ramsay
British Journal of Clinical Pharmacology|December 1, 1987
Ketanserin in essential hypertension: use as monotherapy and in combination with a diuretic or beta-adrenoceptor antagonistH A Cameron, P C Waller, L E Ramsay
Angiology|July 1, 1987
Placebo-controlled trial of ketanserin in the treatment of intermittent claudicationH A Cameron, P C Waller, L E Ramsay
British Journal of Clinical Pharmacology|November 1, 1987
Comparison of ketanserin and slow-release nifedipine added to the treatment of hypertensive patients uncontrolled by a thiazide diuretic plus beta-adrenoceptor blockerP C Waller, S A Solomon, L E Ramsay
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Pharmacoepidemiology and Drug Safety|February 7, 2002
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reportsS J Evans, P C Waller, S Davis
Postgraduate Medical Journal|February 1, 1988
Prolongation of the QT interval by ketanserinH A Cameron, P C Waller, L E Ramsay
Pharmacoepidemiology and Drug Safety|November 1, 1996
Regulatory pharmacovigilance in the United Kingdom: current principles and practiceP C Waller, R A Coulson, S M Wood
Drugs & Aging|March 1, 1992
Pharmacological approaches to the treatment of intermittent claudicationE G Bevan, P C Waller, L E Ramsay
British Journal of Clinical Pharmacology|November 1, 1988
Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965-1985H A Cameron, P C Waller, L E Ramsay
Postgraduate Medical Journal|April 1, 1987
Profound hypotension after the first dose of ketanserinP C Waller, H A Cameron, L E Ramsay
Angiology|March 1, 1989
The acute effects of cigarette smoking on treadmill exercise distances in patients with stable intermittent claudicationP C Waller, S A Solomon, L E Ramsay
British Journal of Clinical Pharmacology|December 1, 1987
Ketanserin in essential hypertension: use as monotherapy and in combination with a diuretic or beta-adrenoceptor antagonistH A Cameron, P C Waller, L E Ramsay
Angiology|July 1, 1987
Placebo-controlled trial of ketanserin in the treatment of intermittent claudicationH A Cameron, P C Waller, L E Ramsay
British Journal of Clinical Pharmacology|November 1, 1987
Comparison of ketanserin and slow-release nifedipine added to the treatment of hypertensive patients uncontrolled by a thiazide diuretic plus beta-adrenoceptor blockerP C Waller, S A Solomon, L E Ramsay
Pageof 5